Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00002692Phase 3Unknown
Phase 3, randomised, open-label trial of fluorouracil in colorectal cancer (CRC) (2 arms), sponsored by Medical Research Council. Primary endpoints: Overall Survival and Objective Response Rate. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00002692.